SOFTBANK CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,878 JPY | +1.57% |
|
+3.33% | +6.76% |
| Apr. 25 | Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln | RE |
| Apr. 15 | Neumora's early-stage schizophrenia drug study put on hold | RE |
Valuation
| Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 5,969,570 | 6,516,704 | 6,734,806 | 6,718,191 | 7,229,673 | 8,921,262 | - | - |
| Enterprise Value (EV) 1 | 8,901,040 | 10,455,148 | 10,842,506 | 10,976,893 | 11,305,007 | 13,014,273 | 12,829,299 | 12,608,594 |
| P/E ratio | 13.9 x | 13.8 x | 13.9 x | 13 x | 13.6 x | 19.1 x | 17.9 x | 16.1 x |
| Yield | 3.01% | 6.18% | 5.98% | 6.02% | 5.62% | 4.58% | 4.59% | 4.66% |
| Capitalization / Revenue | 1.59 x | 1.34 x | 1.29 x | 1.18 x | 1.22 x | 1.45 x | 1.39 x | 1.34 x |
| EV / Revenue | 2.38 x | 2.15 x | 2.08 x | 1.93 x | 1.91 x | 2.11 x | 2 x | 1.89 x |
| EV / EBITDA | 7.6 x | 6.59 x | 6.5 x | 6.42 x | 6.2 x | 8.07 x | 7.64 x | 7.13 x |
| EV / FCF | 20.5 x | 12.8 x | 13.1 x | 42.5 x | 11.3 x | 17.7 x | 15.8 x | 14.9 x |
| FCF Yield | 4.87% | 7.82% | 7.63% | 2.35% | 8.85% | 5.65% | 6.34% | 6.71% |
| Price to Book | 4.79 x | 6.51 x | 4.46 x | 4.01 x | 3.25 x | 3.92 x | 3.77 x | 3.57 x |
| Nbr of stocks (in thousands) | 4,787,145 | 4,741,145 | 4,681,825 | 4,704,616 | 4,728,367 | 4,749,141 | - | - |
| Reference price 2 | 1,247 | 1,374 | 1,438 | 1,428 | 1,529 | 1,878 | 1,878 | 1,878 |
| Announcement Date | 5/8/19 | 5/11/20 | 5/11/21 | 5/11/22 | 5/10/23 | - | - | - |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 3,746,305 | 4,861,247 | 5,205,537 | 5,690,606 | 5,911,999 | 6,160,317 | 6,415,304 | 6,665,671 |
| EBITDA 1 | 1,171,639 | 1,586,966 | 1,667,112 | 1,709,190 | 1,824,378 | 1,613,115 | 1,678,901 | 1,768,717 |
| EBIT 1 | 719,459 | 911,725 | 970,770 | 985,746 | 1,060,168 | 851,481 | 920,805 | 1,008,534 |
| Operating Margin | 19.2% | 18.75% | 18.65% | 17.32% | 17.93% | 13.82% | 14.35% | 15.13% |
| Earnings before Tax (EBT) 1 | 631,548 | 811,195 | 847,699 | 880,363 | 862,868 | 748,280 | 817,783 | 905,230 |
| Net income 1 | 430,777 | 473,135 | 491,287 | 517,517 | 531,366 | 464,933 | 504,209 | 556,319 |
| Net margin | 11.5% | 9.73% | 9.44% | 9.09% | 8.99% | 7.55% | 7.86% | 8.35% |
| EPS 2 | 89.99 | 99.27 | 103.8 | 110.1 | 112.5 | 98.54 | 105.2 | 116.4 |
| Free Cash Flow 1 | 433,363 | 817,752 | 827,654 | 258,225 | 1,000,977 | 735,536 | 813,791 | 846,329 |
| FCF margin | 11.57% | 16.82% | 15.9% | 4.54% | 16.93% | 11.94% | 12.69% | 12.7% |
| FCF Conversion (EBITDA) | 36.99% | 51.53% | 49.65% | 15.11% | 54.87% | 45.6% | 48.47% | 47.85% |
| FCF Conversion (Net income) | 100.6% | 172.84% | 168.47% | 49.9% | 188.38% | 158.2% | 161.4% | 152.13% |
| Dividend per Share 2 | 37.50 | 85.00 | 86.00 | 86.00 | 86.00 | 86.00 | 86.20 | 87.52 |
| Announcement Date | 5/8/19 | 5/11/20 | 5/11/21 | 5/11/22 | 5/10/23 | - | - | - |
1JPY in Million2JPY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: März | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2024 S2 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 | 2025 S2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 2,373,104 | - | 2,428,427 | - | 1,367,660 | 2,724,234 | 1,449,595 | 1,516,777 | - | 1,361,999 | 1,446,556 | 2,808,555 | 1,536,904 | 1,566,540 | 3,103,444 | 1,429,666 | 1,504,092 | 2,933,758 | 1,577,806 | 1,657,623 | 3,226,242 | 1,492,167 | 1,562,425 | 3,058,000 | 1,645,646 | 1,653,008 | 3,362,000 |
| EBITDA 1 | - | - | - | - | 467,734 | - | 430,346 | 345,251 | - | 428,292 | 433,789 | - | 687,727 | - | - | - | - | - | 440,976 | 354,905 | - | 455,000 | 473,000 | - | 420,000 | 372,000 | - |
| EBIT 1 | 551,964 | - | 589,605 | - | 287,747 | 570,846 | 250,365 | 164,535 | - | 247,111 | 251,447 | 498,558 | 483,445 | 78,165 | 561,610 | 246,319 | 268,069 | 514,388 | 217,545 | 115,532 | 345,612 | 267,785 | 283,440 | 562,000 | 243,740 | 136,717 | 378,000 |
| Operating Margin | 23.26% | - | 24.28% | - | 21.04% | 20.95% | 17.27% | 10.85% | - | 18.14% | 17.38% | 17.75% | 31.46% | 4.99% | 18.1% | 17.23% | 17.82% | 17.53% | 13.79% | 6.97% | 10.71% | 17.95% | 18.14% | 18.38% | 14.81% | 8.27% | 11.24% |
| Earnings before Tax (EBT) 1 | 514,243 | - | 531,834 | - | 261,053 | 533,515 | 193,806 | 153,042 | - | 221,869 | 200,177 | 422,046 | 402,303 | 38,519 | 440,822 | 248,621 | 252,352 | 500,973 | 189,488 | 54,017 | 319,027 | 250,500 | 271,000 | 542,000 | 235,000 | 115,500 | 358,000 |
| Net income 1 | 327,424 | - | 315,104 | - | 156,293 | 307,257 | 113,577 | 96,683 | - | 128,542 | 108,599 | 237,141 | 271,465 | 22,760 | 294,225 | 146,719 | 155,422 | 302,141 | 104,541 | 52,438 | 172,278 | 149,258 | 159,595 | 324,978 | 132,322 | 65,436 | 196,178 |
| Net margin | 13.8% | - | 12.98% | - | 11.43% | 11.28% | 7.84% | 6.37% | - | 9.44% | 7.51% | 8.44% | 17.66% | 1.45% | 9.48% | 10.26% | 10.33% | 10.3% | 6.63% | 3.16% | 5.34% | 10% | 10.21% | 10.63% | 8.04% | 3.96% | 5.84% |
| EPS 2 | 68.44 | - | 66.35 | - | 33.27 | 65.45 | 24.15 | 20.53 | - | 27.28 | 23.01 | 50.29 | 57.47 | 4.770 | 62.24 | 30.99 | 32.81 | 63.80 | 22.00 | 8.329 | 36.20 | 32.60 | 35.80 | 68.40 | 33.00 | 8.300 | 41.30 |
| Dividend per Share 2 | 42.50 | 42.50 | 43.00 | 43.00 | 43.00 | 43.00 | - | 43.00 | 43.00 | - | 43.00 | 43.00 | - | 43.00 | 43.00 | - | 43.00 | 43.00 | - | 43.00 | 43.00 | - | 43.00 | 43.00 | - | 43.00 | 43.00 |
| Announcement Date | 11/5/19 | 5/11/20 | 11/4/20 | 5/11/21 | 11/4/21 | 11/4/21 | 2/3/22 | 5/11/22 | 5/11/22 | 8/4/22 | 11/4/22 | 11/4/22 | 2/3/23 | 5/10/23 | 5/10/23 | 8/4/23 | 11/8/23 | 11/8/23 | 2/7/24 | - | - | - | - | - | - | - | - |
1JPY in Million2JPY
Estimates
Balance Sheet Analysis
| Fiscal Period: März | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 2,931,470 | 3,938,444 | 4,107,700 | 4,258,702 | 4,075,334 | 4,093,011 | 3,908,037 | 3,687,332 |
| Net Cash position 1 | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 2.502 x | 2.482 x | 2.464 x | 2.492 x | 2.234 x | 2.537 x | 2.328 x | 2.085 x |
| Free Cash Flow 1 | 433,363 | 817,752 | 827,654 | 258,225 | 1,000,977 | 735,536 | 813,791 | 846,329 |
| ROE (net income / shareholders' equity) | 40.8% | 37.9% | 39.1% | 32.2% | 25.4% | 21.2% | 22% | 23.2% |
| ROA (Net income/ Total Assets) | 7.78% | 10.4% | 7.7% | 7.06% | 6.3% | 3.67% | 3.45% | 3.69% |
| Assets 1 | 5,540,305 | 4,539,867 | 6,380,574 | 7,328,837 | 8,433,605 | 12,656,890 | 14,621,733 | 15,066,716 |
| Book Value Per Share 2 | 261.0 | 211.0 | 323.0 | 356.0 | 470.0 | 479.0 | 498.0 | 527.0 |
| Cash Flow per Share 2 | 184.0 | 241.0 | 251.0 | 264.0 | 274.0 | 236.0 | 259.0 | 270.0 |
| Capex 1 | 393,219 | 431,783 | 479,522 | 709,092 | 788,609 | 639,827 | 626,356 | 641,125 |
| Capex / Sales | 10.5% | 8.88% | 9.21% | 12.46% | 13.34% | 10.39% | 9.76% | 9.62% |
| Announcement Date | 5/8/19 | 5/11/20 | 5/11/21 | 5/11/22 | 5/10/23 | - | - | - |
1JPY in Million2JPY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
17
Last Close Price
1,878
JPY
Average target price
1,900
JPY
Spread / Average Target
+1.13%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +6.76% | 56.67B | |
| +28.33% | 94.52B | |
| -11.97% | 23.64B | |
| -16.38% | 20.55B | |
| -12.50% | 11.16B | |
| +5.61% | 10.64B | |
| +2.45% | 10.28B | |
| +0.88% | 8.9B | |
| -25.24% | 8.29B | |
| +20.93% | 6.61B |
- Stock Market
- Equities
- 9434 Stock
- Financials SoftBank Corp.
